CIP
XENT

Chartwell Investment Partners’s Intersect ENT, Inc XENT Stock Holding History

Chartwell Investment Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-58,335
Closed -$2.29M – 512
2018
Q1 		$2.29M Buy
+58,335
New +$2.13M 0.08% 278

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Chartwell Investment Partners's XENT Position: Q2 2018 in Review

Chartwell Investment Partners sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 58,335 shares — an estimated $2.29M sold.

Chartwell Investment Partners first reported a position in XENT in Q1 2018 and held it in 1 quarter. The position peaked at $2.29M in Q1 2018. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Chartwell Investment Partners reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Chartwell Investment Partners sold 58,335 Intersect ENT, Inc shares in Q2 2018, an estimated $2.29M.
  • Chartwell Investment Partners first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 1 quarter.
  • Chartwell Investment Partners's Intersect ENT, Inc position peaked at $2.29M in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Chartwell Investment Partners's 13F filing for Q2 2018, filed 9 Aug 2018.